Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CL
CUSIP19416210
Phone212-310-2000
Debt
Debt-to-Equity Ratio-34.49
Current Ratio1.06
Quick Ratio0.74
Price-To-Earnings
Trailing P/E Ratio23.67
Forward P/E Ratio22.49
P/E Growth3.05
Sales & Book Value
Annual Sales$15.45 billion
Price / Sales3.81
Cash Flow$3.4222 per share
Price / Cash19.85
Book Value$0.28 per share
Price / Book242.61
Profitability
EPS (Most Recent Fiscal Year)$2.87
Net Income$2.02 billion
Net Margins13.97%
Return on Equity2,494.79%
Return on Assets20.54%
Miscellaneous
Employees35,900
Outstanding Shares867,740,000
Market Cap$59.23 billion
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive declared a quarterly dividend on Thursday, September 13th. Stockholders of record on Friday, October 19th will be given a dividend of $0.42 per share on Thursday, November 15th. This represents a $1.68 annualized dividend and a dividend yield of 2.47%. The ex-dividend date of this dividend is Thursday, October 18th. View Colgate-Palmolive's Dividend History.
How will Colgate-Palmolive's stock buyback program work?
Colgate-Palmolive declared that its Board of Directors has approved a stock buyback program on Monday, June 18th 2018, which allows the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its shares are undervalued.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) released its earnings results on Friday, July, 27th. The company reported $0.77 EPS for the quarter, hitting the consensus estimate of $0.77. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.91 billion. Colgate-Palmolive had a return on equity of 2,494.79% and a net margin of 13.97%. The company's quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.72 EPS. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
16 equities research analysts have issued 12 month target prices for Colgate-Palmolive's stock. Their predictions range from $64.00 to $85.00. On average, they anticipate Colgate-Palmolive's share price to reach $71.5714 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.
What is the consensus analysts' recommendation for Colgate-Palmolive?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. According to Zacks Investment Research, "Colgate topped the industry in the past month courtesy of focus on brand building and productivity maximization initiatives. This helped the company retain its meet or beat earnings track record, with in line earnings in second-quarter 2018. Colgate expects double-digit increase in GAAP earnings per share in 2018 fueled by the expanded Global Growth and Efficiency Program. Further, it estimates mid-single-digit adjusted earnings per share growth. Moreover, the company’s foray in organic products with the rollout of the Naturals range in Asia and across Europe and expected launches in Latin America and Africa Euroasia bodes well. However, the company’s margins continue to be strained due to higher raw material and packaging costs. Further, its top line missed estimates in 16 of the last 17 quarters. Additionally, the company expects a challenging backdrop in 2018 due to uncertain global markets and slowing category growth worldwide." (9/18/2018)
- 2. Wells Fargo & Co analysts commented, "We maintain our FY18/FY19 EPS estimates by $3.02/$3.27 and our $64 price target." (7/27/2018)
- 3. Jefferies Financial Group Inc analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Mandom (MDOMF), Revlon (REV), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM).
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Chairman & CEO (Age 65)
- Mr. Noel R. Wallace, Pres & COO (Age 54)
- Mr. Dennis J. Hickey, Vice Chairman (Age 70)
- Mr. Franck J. Moison, Vice Chairman (Age 64)
- Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 58)
Has Colgate-Palmolive been receiving favorable news coverage?
News articles about CL stock have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Colgate-Palmolive earned a daily sentiment score of 0.18 on Accern's scale. They also assigned press coverage about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Colgate-Palmolive.
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.16%), Massachusetts Financial Services Co. MA (3.73%), Bank of New York Mellon Corp (2.32%), Bank of New York Mellon Corp (2.32%), Northern Trust Corp (1.22%) and FMR LLC (0.91%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.
Which institutional investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Morgan Stanley, Canada Pension Plan Investment Board, BlackRock Inc., Newport Trust Co, Russell Investments Group Ltd. and NN Investment Partners Holdings N.V.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.
Which institutional investors are buying Colgate-Palmolive stock?
CL stock was acquired by a variety of institutional investors in the last quarter, including Fundsmith Equity Fund L.P., Massachusetts Financial Services Co. MA, Charles Schwab Investment Advisory Inc., Bank of New York Mellon Corp, Bank of New York Mellon Corp, Flossbach Von Storch AG, Natixis and Intermede Investment Partners Ltd. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $67.93.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $59.23 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
